RG
Robert Glaser
Director

Robert Glaser insider trades: Viropharma (VPHM) stock buys and sales

Director, Viropharma Last trade Nov 30, 2012 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
1
Company
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 30, 2012VPHM↓ Sell$743K
Nov 28, 2011VPHM↓ Sell$115K
Dec 14, 2010VPHM↓ Sell$84K
May 27, 2010VPHM↓ Sell$63K
Feb 7, 2007VPHM↓ Sell$180K
Jan 30, 2007VPHM↓ Sell$43K
Jan 25, 2007VPHM↓ Sell$40K
Dec 13, 2005VPHM↓ Sell$593K
Jun 6, 2005VPHM↑ Buy$68K
May 19, 2005VPHM↑ Buy$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert Glaser's insider trades

Robert Glaser is a director at Viropharma (VPHM). Since May 19, 2005, Robert has reported 2 open-market purchases worth $97K and 8 sales worth $1.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), option exercises (7 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VPHM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.